Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing platforms for unmatched quality and scale. For research and pharma innovators, ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Learn how to leverage the power of multiomics without the steep learning curve of bioinformatics. With intuitive interfaces and powerful analytical tools, you can unlock comprehensive biological ...

Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...

SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) announced on Tuesday the release of Illumina Connected Multiomics, a cloud-based research software platform designed to analyze and visualize multiomic ...

DNA sequencing company Illumina and Nashville Biosciences, a wholly owned subsidiary of Nashville, Tenn.-based Vanderbilt University Medical Center, are working with biopharmaceutical company Amgen to ...